Survey of the management of borderline ovarian tumors in the United Kingdom
World Journal of Obstetrics and Gynecology · 2012
DOI: 10.5317/wjog.v1.i2.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Obstetrics and Gynecology, 2012. Verfasst von Amy Winser. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Borderline ovarian tumors (BOTs) represent approximately 10% of ovarian neoplasms and are a heterogeneous group of tumors with variable biological behaviour. The majority present with disease confined to the ovary and have an excellent prognosis after surgical removal. A small proportion subsequently has recurrent disease or progression to invasive cancer. Tumor recurrence can occur up to 20 years after surgical resection. There are no robust clinical, histological or molecular markers that distinguish high risk cases and no satisfactory treatment for patients with progressive disease. This results in great variability in management in different centres. We conducted a national survey on the management of borderline ovarian tumors in cancer centres representing different regions in the United Kingdom. In this article we review the literature for the current concepts in diagnosis, treatment and follow up of BOTs and we report the results of the survey of current practice in the United Kingdom. On that basis we provide recommendations for the management of pa-
Zitieren
APA
Winser, A. (2012). Survey of the management of borderline ovarian tumors in the United Kingdom. World Journal of Obstetrics and Gynecology. https://doi.org/10.5317/wjog.v1.i2.3
Vancouver
Winser A. Survey of the management of borderline ovarian tumors in the United Kingdom. World Journal of Obstetrics and Gynecology. 2012. doi:10.5317/wjog.v1.i2.3
BibTeX
@article{Winser2012,
author = {Winser, Amy},
title = {Survey of the management of borderline ovarian tumors in the United Kingdom},
journal = {World Journal of Obstetrics and Gynecology},
year = {2012},
doi = {10.5317/wjog.v1.i2.3}
}
EUVIMED